Literature DB >> 3513747

Q-switched neodymium-YAG laser iridotomy in patients in whom the argon laser fails.

A L Robin, I P Pollack.   

Abstract

We conducted a short-term prospective clinical study to evaluate Q-switched neodymium-YAG laser iridotomy in 33 eyes with pupillary block glaucoma in which the argon laser was unable to create an iridotomy. These eyes had chronic angle closure glaucoma (11 eyes), acute angle closure glaucoma (five eyes), pseudophakic pupillary block (seven eyes), uveitic pupillary block (three eyes), and contralateral eyes (five eyes); also included were both eyes of a patient with a head tremor. In all eyes, a patent iridotomy was created in one treatment session, with a mean of 5 +/- 5 pulses and a mean total energy of 55 +/- 120 millijoules. Complications included iridotomy closure (two eyes with preexisting active uveitis), focal nonprogressive corneal opacities (six eyes), and minimal bleeding from the iridotomy margin (12 eyes). Q-switched neodymium-YAG laser iridotomy appears to be an effective next step in the management of pupillary block glaucoma prior to surgical iridectomy when argon laser iridotomy fails.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513747     DOI: 10.1001/archopht.1986.01050160087018

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  4 in total

Review 1.  Laser light: its nature and its action on the eye.

Authors:  F M Bessette; L C Nguyen
Journal:  CMAJ       Date:  1989-12-01       Impact factor: 8.262

2.  Sequential argon-YAG laser iridotomies in dark irides.

Authors:  T Ho; R Fan
Journal:  Br J Ophthalmol       Date:  1992-06       Impact factor: 4.638

3.  [Cataract extraction including posterior chamber lens implantation in the treatment of acute glaucoma].

Authors:  H Bleckmann; R Keuch
Journal:  Ophthalmologe       Date:  2006-03       Impact factor: 1.059

4.  Argon laser iridotomy-induced bullous keratopathy a growing problem in Japan.

Authors:  Leonard P K Ang; Hisayo Higashihara; Chie Sotozono; Vijay A Shanmuganathan; Harminder Dua; Donald T H Tan; Shigeru Kinoshita
Journal:  Br J Ophthalmol       Date:  2007-06-13       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.